Arbor Vita Announces HPV E6 Test Interim Study Results

Arbor Vita has announced the interim clinical study results for the Company's HPV E6 Test for cervical cancer and precancerous lesions. Results validated the utility of Arbor Vita's HPV E6 Test to detect the cancer-causing E6 protein, a biomarker for cervical cancer and precancerous lesions. The E6 oncoprotein is expressed at elevated levels in cervical swab samples only when HPV-infected cervical cells undergo precancerous and cancerous changes. The study findings were presented at the 27th International Papillomavirus Conference (IPV) in Berlin, Germany. Read more...